相关实验视频

Updated: Jul 18, 2025

CRISPR/Cas9 Technology in Restoring Dystrophin Expression in iPSC-Derived Muscle Progenitors

CRISPR/Cas9 Technology in Restoring Dystrophin Expression in iPSC-Derived Muscle Progenitors

Published on: September 14, 2019

双CRISPR-Cas3系统用于诱导DMD患者衍生的iPSCs中的多外显子跳转

Yuto Kita¹, Yuya Okuzaki², Youichi Naoe¹

¹Center for iPS Cell Research and Application, Kyoto University, 53 Shogoin-Kawahara-cho, Sakyo-ku, Kyoto 606-8507, Japan.

Stem cell reports

|August 25, 2023

概括

研究人员使用CRISPR-Cas3创建大基因组删除杜氏肌肉发育不良 (DMD) 基因治疗. 这种多外显子跳转 (MES) 方法成功地在患者细胞中恢复了双蛋白,并最小化了目标外影响.

科学领域:

分子生物学分子生物学
基因编辑技术的技术
遗传学是一个遗传学.

背景情况:

杜氏肌肉发育不良 (DMD) 是一种遗传性疾病,其特点是缺乏蛋白.
目前对DMD的治疗策略,如多表因子跳转 (MES),在诱导某些突变模式所需的大型基因组删除方面面临挑战.
有效地准和删除大型DNA段对于恢复DMD患者的双素生产至关重要.

研究的目的:

调查CRISPR-Cas3系统在诱导基于MES的DMD疗法中素基因的大型基因组删除中的有效性.
开发和验证用于丰富基因组编辑细胞的报告系统.
评估CRISPR-Cas3中介的大型删除的安全性和特异性.

主要方法:

使用双CRISPR-Cas3系统与crRNAs准并诱导在大型删除 (大约340 kb) 在dystrophin exon 45-55区域.
开发了一种基于SSA的双色记者系统,以促进Cas3编辑细胞的丰富.
采用全基因组测序来评估在预期目标地点附近的非目标删除事件.

主要成果:

证明双重的CRISPR-Cas3成功诱导了斯特罗芬基因的目标大删除.
在诱导多能干细胞 (iPSCs) 中恢复了双蛋白表达,这些干细胞来自三种不同的突变的DMD患者.
全基因组测序显示没有显著的非目标删除,表明CRISPR-Cas3系统的高特异性.

结论:

双CRISPR-Cas3系统是一个强大的工具,可以产生大量的基因组删除,这对于杜氏肌肉发育不良症中多个表因子跳转是必要的.
这种方法显示出通过恢复双蛋白来治疗DMD的各种突变类型的前景.
通过CRISPR-Cas3介导的大删除为DMD基因疗法提供了一种安全有效的策略,具有最小的目标外关注.

关键词:

这就是CRISPR-Cas3.在 DMD DMD 里面,你会发现突出跳过的突出跳过基因治疗的基因疗法基因组编辑基因组编辑

更多相关视频

Direct Reprogramming of Human Fibroblasts into Myoblasts to Investigate Therapies for Neuromuscular Disorders

Direct Reprogramming of Human Fibroblasts into Myoblasts to Investigate Therapies for Neuromuscular Disorders

Published on: April 3, 2021

Multi-exon Skipping Using Cocktail Antisense Oligonucleotides in the Canine X-linked Muscular Dystrophy

Multi-exon Skipping Using Cocktail Antisense Oligonucleotides in the Canine X-linked Muscular Dystrophy

Published on: May 24, 2016

相关概念视频

CRISPR/Cas9 Genome Editing

CRISPR/Cas9 Genome Editing

The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...

CRISPR

CRISPR

Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...